Rx Firms Hold Line Against Forced OTC Switches – And Possible Lost Sales

Though FDA's authority to force Rx-to-OTC switches of pharmaceutical products remains unresolved going into 2004, industry has left no uncertainty about its position - delineating a hard-line stance against any such move